Geron cuts one-third of staff, focusing on turning Rytelo launch aroundnews2025-12-11T20:24:29+00:00December 11th, 2025|Endpoints News|
EU forges deal over major pharma legislative changesnews2025-12-11T20:00:58+00:00December 11th, 2025|Endpoints News|
GSK’s new antibiotic wins gonorrhea approvalnews2025-12-11T19:19:37+00:00December 11th, 2025|Endpoints News|
Top Trump lawyer calls on SCOTUS to reverse ‘skinny’ generic drug label decisionnews2025-12-11T19:05:07+00:00December 11th, 2025|Endpoints News|
Umoja delays first readout for in vivo CAR-T therapynews2025-12-11T16:31:16+00:00December 11th, 2025|Endpoints News|
Rezolute crashes as its only drug fails in Phase 3news2025-12-11T16:20:43+00:00December 11th, 2025|Endpoints News|
Rhythm reports Imcivree’s key weight loss data from Phase 2 Prader-Willi trialnews2025-12-11T16:17:38+00:00December 11th, 2025|Endpoints News|
AC Immune says early biomarker data are promising in Parkinson’s, but clinical benefit remains unclearnews2025-12-11T15:31:37+00:00December 11th, 2025|Endpoints News|
Corbus’ obesity pill posts muted weight loss data; Disco adds another €16M in seed fundingnews2025-12-11T15:15:16+00:00December 11th, 2025|Endpoints News|
Health tech investors are getting creative with exitsnews2025-12-11T14:00:06+00:00December 11th, 2025|Endpoints News|
